Status:
COMPLETED
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
A new coronavirus (COVID-19) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating benign symptoms (such as fe...
Detailed Description
The main objective of this project is to set up a biological and tissue collection in order to study the transplacental passage of the SARS-CoV-2 virus, and the pregnancy outcomes (miscarriage, intra ...
Eligibility Criteria
Inclusion
- Women over 18 years old on the date of inclusion
- Pregnant women coming to deliver in the Paule de Viguier maternity unit of Toulouse's University Hospital between April 2020 and April 2021 regardless the pregnancy outcomes (live births, IUFD, miscarriages, medical termination of pregnancy ) and the term
- Women affiliated to a social security system (including AME)
Exclusion
- Voluntary termination of pregnancy
- Language barrier
- Patient under a legal protection measure (guardianship, curatorship, or safeguard of justice)
Key Trial Info
Start Date :
April 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
2494 Patients enrolled
Trial Details
Trial ID
NCT04360811
Start Date
April 17 2020
End Date
March 31 2022
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Toulouse
Toulouse, France, 31000